信息搜索
信息关键字：药
  

共有5246条记录

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239] [240] [241] [242] [243] [244] [245] [246] [247] [248] [249] [250] [251] [252] [253] [254] [255] [256] [257] [258] [259] [260] [261] [262] [263]

·辉瑞新冠口服药附条件获批概念股开盘走强2022-2-14 13:16:57
·突发！“医药女神”基金被支付宝榜单“摘牌”蚂蚁财富回应2022-2-14 13:00:05
·情人劫券商板块大跌！新冠药物板块大爆发多股狂掀20%涨停！宁王大反攻2022-2-14 12:46:53
·一则消息引爆新冠药概念！雅本化学20CM涨停宁德时代重返500元上方！后市咋看？2022-2-14 11:54:16
·新冠小分子药相关企业股价集体飙涨供应商备战扩大产能2022-2-14 11:10:05
·是否有能力为药企提供天然菊酯？晨光生物：暂无相关产品2022-2-14 10:57:10
·歌礼制药B(01672)早盘高开逾12%批准辉瑞公司新冠病毒治疗药物奈玛特韦片/利托那韦片组合包装(即Paxlovid)进口注册2022-2-14 10:02:37
·上海谊众“牵手”百洋医药共同加速肿瘤创新药物商业化2022-2-14 9:58:42
·辉瑞新冠病毒治疗药物再下一城相关概念股开盘走强2022-2-14 9:36:48
·“顶流”药明康德何时能“止血”？2022-2-14 8:58:16
·中信建投：新冠口服药物商业化潜力巨大利好小分子CDMO龙头2022-2-14 7:58:12
·辉瑞新冠口服药附条件获批概念股获机构集中关注4股净利润有望翻倍2022-2-14 7:54:28
·首款新冠口服药获批进口住院死亡风险降89％！国内药企什么进度了？2022-2-13 23:56:39
·【医药】祝嘉琦：辉瑞新冠药国内EUAODAC落地医药有望触底回升2022-2-13 22:20:10
·关注！辉瑞新冠口服药国内获批这些A股公司已提前布局2022-2-13 21:21:29
·上海谊众：与百洋医药签订市场推广服务协议2022-2-13 18:06:52
·医药基金年内平均大跌近20%！还值得买吗？2022-2-13 17:11:27
·火药味越来越浓！拜登通报西方，俄军16日发动进攻……2022-2-13 16:58:15
·医药基金年内平均大跌近20%！还值得买吗？2022-2-13 16:57:50
·搭上“元宇宙”概念的超图软件最受关注，红杉、景林扎堆华东医药|2022-2-13 14:11:46

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239] [240] [241] [242] [243] [244] [245] [246] [247] [248] [249] [250] [251] [252] [253] [254] [255] [256] [257] [258] [259] [260] [261] [262] [263]